Lentigo Maligna on a Difficult Location of the Face Treated with 5% Imiquimod: A Case Report of 2-Year Follow-Up

Topical imiquimod is an off-label alternative treatment for lentigo maligna used when surgery cannot be performed. Severe inflammatory response induced by this drug may generate many complaints and force patients to discontinue use. We present a case in which interval treatment with 5% topical imiqu...

Descripción completa

Detalles Bibliográficos
Autores principales: Misiak-Galazka, Magdalena, Czuwara, Joanna, Galazka, Adam, Czaplicka, Anna, Rudnicka, Lidia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850510/
https://www.ncbi.nlm.nih.gov/pubmed/35083713
http://dx.doi.org/10.1007/s13555-021-00667-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850510/
https://www.ncbi.nlm.nih.gov/pubmed/35083713
http://dx.doi.org/10.1007/s13555-021-00667-w

Ejemplares similares